A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)

Name: A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)
Published: 2025
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

rcc, tyrosine kinase inhibitors, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)

Related documents